Medpace Holdings Inc
NASDAQ:MEDP

Watchlist Manager
Medpace Holdings Inc Logo
Medpace Holdings Inc
NASDAQ:MEDP
Watchlist
Price: 369.26 USD 4.48% Market Closed
Market Cap: 11.4B USD
Have any thoughts about
Medpace Holdings Inc?
Write Note

Medpace Holdings Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Medpace Holdings Inc
Revenue Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Medpace Holdings Inc
NASDAQ:MEDP
Revenue
$2.1B
CAGR 3-Years
24%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Revenue
$42.4B
CAGR 3-Years
3%
CAGR 5-Years
11%
CAGR 10-Years
10%
Danaher Corp
NYSE:DHR
Revenue
$21.2B
CAGR 3-Years
-9%
CAGR 5-Years
6%
CAGR 10-Years
1%
Mettler-Toledo International Inc
NYSE:MTD
Revenue
$3.8B
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
4%
Agilent Technologies Inc
NYSE:A
Revenue
$6.5B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
13%
IQVIA Holdings Inc
NYSE:IQV
Revenue
$15.3B
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
11%

Medpace Holdings Inc
Revenue Breakdown

Breakdown by Geography
Medpace Holdings Inc

Not Available

Breakdown by Segments
Medpace Holdings Inc

Total Revenue: 1.9B USD
100%
Revenue Net: 1.9B USD
100%
Oncology: 587.1m USD
31.1%
Other: 404.8m USD
21.5%
Metabolic: 376.8m USD
20%
Cardiology: 193.7m USD
10.3%
Avai: 163.3m USD
8.7%
Central Nervous System: 160.1m USD
8.5%
Show More
Show Less

See Also

What is Medpace Holdings Inc's Revenue?
Revenue
2.1B USD

Based on the financial report for Sep 30, 2024, Medpace Holdings Inc's Revenue amounts to 2.1B USD.

What is Medpace Holdings Inc's Revenue growth rate?
Revenue CAGR 5Y
20%

Over the last year, the Revenue growth was 16%. The average annual Revenue growth rates for Medpace Holdings Inc have been 24% over the past three years , 20% over the past five years .

Back to Top